Copyright Reports & Markets. All rights reserved.

Global Dry Powder Inhalation Excipients Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Dry Powder Inhalation Excipients Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Lactose
    • 1.3.3 Magnesium Stearate
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Dry Powder Inhalation Excipients Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 DPI
    • 1.4.3 MDI
    • 1.4.4 Nebulizer
    • 1.4.5 Others
  • 1.5 Global Dry Powder Inhalation Excipients Market Size & Forecast
    • 1.5.1 Global Dry Powder Inhalation Excipients Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Dry Powder Inhalation Excipients Sales Quantity (2021-2032)
    • 1.5.3 Global Dry Powder Inhalation Excipients Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Protheragen-ING
    • 2.1.1 Protheragen-ING Details
    • 2.1.2 Protheragen-ING Major Business
    • 2.1.3 Protheragen-ING Dry Powder Inhalation Excipients Product and Services
    • 2.1.4 Protheragen-ING Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Protheragen-ING Recent Developments/Updates
  • 2.2 DFE Pharma
    • 2.2.1 DFE Pharma Details
    • 2.2.2 DFE Pharma Major Business
    • 2.2.3 DFE Pharma Dry Powder Inhalation Excipients Product and Services
    • 2.2.4 DFE Pharma Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 DFE Pharma Recent Developments/Updates
  • 2.3 Meggle-Pharma
    • 2.3.1 Meggle-Pharma Details
    • 2.3.2 Meggle-Pharma Major Business
    • 2.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Product and Services
    • 2.3.4 Meggle-Pharma Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Meggle-Pharma Recent Developments/Updates
  • 2.4 Pfanstiehl
    • 2.4.1 Pfanstiehl Details
    • 2.4.2 Pfanstiehl Major Business
    • 2.4.3 Pfanstiehl Dry Powder Inhalation Excipients Product and Services
    • 2.4.4 Pfanstiehl Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pfanstiehl Recent Developments/Updates
  • 2.5 Merck
    • 2.5.1 Merck Details
    • 2.5.2 Merck Major Business
    • 2.5.3 Merck Dry Powder Inhalation Excipients Product and Services
    • 2.5.4 Merck Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merck Recent Developments/Updates
  • 2.6 Sheffield (Kerry)
    • 2.6.1 Sheffield (Kerry) Details
    • 2.6.2 Sheffield (Kerry) Major Business
    • 2.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Product and Services
    • 2.6.4 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sheffield (Kerry) Recent Developments/Updates
  • 2.7 Armor Pharma
    • 2.7.1 Armor Pharma Details
    • 2.7.2 Armor Pharma Major Business
    • 2.7.3 Armor Pharma Dry Powder Inhalation Excipients Product and Services
    • 2.7.4 Armor Pharma Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Armor Pharma Recent Developments/Updates
  • 2.8 Abbott
    • 2.8.1 Abbott Details
    • 2.8.2 Abbott Major Business
    • 2.8.3 Abbott Dry Powder Inhalation Excipients Product and Services
    • 2.8.4 Abbott Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Abbott Recent Developments/Updates
  • 2.9 Norvatis
    • 2.9.1 Norvatis Details
    • 2.9.2 Norvatis Major Business
    • 2.9.3 Norvatis Dry Powder Inhalation Excipients Product and Services
    • 2.9.4 Norvatis Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Norvatis Recent Developments/Updates
  • 2.10 Bayer
    • 2.10.1 Bayer Details
    • 2.10.2 Bayer Major Business
    • 2.10.3 Bayer Dry Powder Inhalation Excipients Product and Services
    • 2.10.4 Bayer Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bayer Recent Developments/Updates
  • 2.11 Jiangsu Daoning Drug
    • 2.11.1 Jiangsu Daoning Drug Details
    • 2.11.2 Jiangsu Daoning Drug Major Business
    • 2.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product and Services
    • 2.11.4 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Jiangsu Daoning Drug Recent Developments/Updates

3 Competitive Environment: Dry Powder Inhalation Excipients by Manufacturer

  • 3.1 Global Dry Powder Inhalation Excipients Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Dry Powder Inhalation Excipients Revenue by Manufacturer (2021-2026)
  • 3.3 Global Dry Powder Inhalation Excipients Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Dry Powder Inhalation Excipients by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Dry Powder Inhalation Excipients Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Dry Powder Inhalation Excipients Manufacturer Market Share in 2025
  • 3.5 Dry Powder Inhalation Excipients Market: Overall Company Footprint Analysis
    • 3.5.1 Dry Powder Inhalation Excipients Market: Region Footprint
    • 3.5.2 Dry Powder Inhalation Excipients Market: Company Product Type Footprint
    • 3.5.3 Dry Powder Inhalation Excipients Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Dry Powder Inhalation Excipients Market Size by Region
    • 4.1.1 Global Dry Powder Inhalation Excipients Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Dry Powder Inhalation Excipients Consumption Value by Region (2021-2032)
    • 4.1.3 Global Dry Powder Inhalation Excipients Average Price by Region (2021-2032)
  • 4.2 North America Dry Powder Inhalation Excipients Consumption Value (2021-2032)
  • 4.3 Europe Dry Powder Inhalation Excipients Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Dry Powder Inhalation Excipients Consumption Value (2021-2032)
  • 4.5 South America Dry Powder Inhalation Excipients Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Dry Powder Inhalation Excipients Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Dry Powder Inhalation Excipients Sales Quantity by Type (2021-2032)
  • 5.2 Global Dry Powder Inhalation Excipients Consumption Value by Type (2021-2032)
  • 5.3 Global Dry Powder Inhalation Excipients Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Dry Powder Inhalation Excipients Sales Quantity by Application (2021-2032)
  • 6.2 Global Dry Powder Inhalation Excipients Consumption Value by Application (2021-2032)
  • 6.3 Global Dry Powder Inhalation Excipients Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Dry Powder Inhalation Excipients Sales Quantity by Type (2021-2032)
  • 7.2 North America Dry Powder Inhalation Excipients Sales Quantity by Application (2021-2032)
  • 7.3 North America Dry Powder Inhalation Excipients Market Size by Country
    • 7.3.1 North America Dry Powder Inhalation Excipients Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Dry Powder Inhalation Excipients Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Dry Powder Inhalation Excipients Sales Quantity by Type (2021-2032)
  • 8.2 Europe Dry Powder Inhalation Excipients Sales Quantity by Application (2021-2032)
  • 8.3 Europe Dry Powder Inhalation Excipients Market Size by Country
    • 8.3.1 Europe Dry Powder Inhalation Excipients Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Dry Powder Inhalation Excipients Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Dry Powder Inhalation Excipients Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Dry Powder Inhalation Excipients Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Dry Powder Inhalation Excipients Market Size by Region
    • 9.3.1 Asia-Pacific Dry Powder Inhalation Excipients Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Dry Powder Inhalation Excipients Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Dry Powder Inhalation Excipients Sales Quantity by Type (2021-2032)
  • 10.2 South America Dry Powder Inhalation Excipients Sales Quantity by Application (2021-2032)
  • 10.3 South America Dry Powder Inhalation Excipients Market Size by Country
    • 10.3.1 South America Dry Powder Inhalation Excipients Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Dry Powder Inhalation Excipients Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Dry Powder Inhalation Excipients Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Dry Powder Inhalation Excipients Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Dry Powder Inhalation Excipients Market Size by Country
    • 11.3.1 Middle East & Africa Dry Powder Inhalation Excipients Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Dry Powder Inhalation Excipients Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Dry Powder Inhalation Excipients Market Drivers
  • 12.2 Dry Powder Inhalation Excipients Market Restraints
  • 12.3 Dry Powder Inhalation Excipients Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Dry Powder Inhalation Excipients and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Dry Powder Inhalation Excipients
  • 13.3 Dry Powder Inhalation Excipients Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Dry Powder Inhalation Excipients Typical Distributors
  • 14.3 Dry Powder Inhalation Excipients Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Dry Powder Inhalation Excipients market size was valued at US$ 1870 million in 2025 and is forecast to a readjusted size of US$ 2669 million by 2032 with a CAGR of 5.3% during review period.
    Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.
    This report is a detailed and comprehensive analysis for global Dry Powder Inhalation Excipients market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Dry Powder Inhalation Excipients market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Dry Powder Inhalation Excipients market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Dry Powder Inhalation Excipients market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Dry Powder Inhalation Excipients market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Dry Powder Inhalation Excipients
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Dry Powder Inhalation Excipients market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Dry Powder Inhalation Excipients market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Lactose
    Magnesium Stearate
    Others
    Market segment by Application
    DPI
    MDI
    Nebulizer
    Others
    Major players covered
    Protheragen-ING
    DFE Pharma
    Meggle-Pharma
    Pfanstiehl
    Merck
    Sheffield (Kerry)
    Armor Pharma
    Abbott
    Norvatis
    Bayer
    Jiangsu Daoning Drug
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Dry Powder Inhalation Excipients product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Dry Powder Inhalation Excipients, with price, sales quantity, revenue, and global market share of Dry Powder Inhalation Excipients from 2021 to 2026.
    Chapter 3, the Dry Powder Inhalation Excipients competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Dry Powder Inhalation Excipients breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Dry Powder Inhalation Excipients market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Dry Powder Inhalation Excipients.
    Chapter 14 and 15, to describe Dry Powder Inhalation Excipients sales channel, distributors, customers, research findings and conclusion.

    Buy now